Michael Gilman
- Molecular Biology top 0.5%
- RNA and protein synthesis mechanisms 10
- DNA Repair Mechanisms 6
- RNA modifications and cancer 6
- Signaling Pathways in Disease 6
- Immunology top 1%
- Oncology top 1%
- Genetics top 0.5%
- Virus-based gene therapy research 9
- Bacterial Genetics and Biotechnology 6
- Cancer Research top 2%
- NF-κB Signaling Pathways 6
-
- Bacteriophages and microbial interactions 9
- Co-authors
- Sridaran NatesanRobert A. WeinbergHenry B. SadowskiMichael J. ChamberlinVictor M. RiveraLaura A. BerkowitzKarl RiabowolDouglas A. Harrison
- Cited by
- Molecular BiologyImmunologyOncology
- Journals
- Molecular and Cellular Biology (13 papers)Proceedings of the National Academy of Sciences (10 papers)Science (4 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Michael Gilman
67 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Molecular Biology 6.5k
- Immunology 1.6k
- Oncology 2.0k
- Genetics 1.8k
- Cancer Research 774
Countries citing papers authored by Michael Gilman
This map shows the geographic impact of Michael Gilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gilman more than expected).
Fields of papers citing papers by Michael Gilman
This network shows the impact of papers produced by Michael Gilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gilman. The network helps show where Michael Gilman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Gilman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | Cloning the Soil Metagenome: a Strategy for Accessing the Genetic and Functional Diversity of Uncultured Microorganismsbreakdown → | 2000 | 780 |
| 3 | 1999 | 292 | |
| 4 | 1999 | 9 | |
| 5 | 1999 | 169 | |
| 6 | 1999 | 148 | |
| 7 | 1997 | 117 | |
| 8 | 1997 | 42 | |
| 9 | 1996 | 433 | |
| 10 | 1995 | 46 | |
| 11 | 1995 | 80 | |
| 12 | 1994 | 40 | |
| 13 | 1993 | 429 | |
| 14 | 1993 | 2 | |
| 15 | 1993 | 249 | |
| 16 | Recombinant DNA- Second Edition | 1992 | 7 |
| 17 | 1992 | 32 | |
| 18 | 1990 | 124 | |
| 19 | 1989 | 127 | |
| 20 | 枯草菌σ 28 および大腸菌σ 32 (htpR)は重複プロモータ特異性を示す微量σ因子である | 1985 | 3 |
About Michael Gilman
Michael Gilman is a scholar working on Genetics, Molecular Biology and Cancer Research, having authored 68 papers that have together received 9.1k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (10 papers), Virus-based gene therapy research (9 papers), Bacteriophages and microbial interactions (9 papers), DNA Repair Mechanisms (6 papers), RNA modifications and cancer (6 papers), Signaling Pathways in Disease (6 papers), Bacterial Genetics and Biotechnology (6 papers) and NF-κB Signaling Pathways (6 papers). The work is most often cited by research in Molecular Biology (6.5k citations), Immunology (1.6k citations) and Oncology (2.0k citations). Michael Gilman has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Sridaran Natesan, Robert A. Weinberg, Henry B. Sadowski, Michael J. Chamberlin, Victor M. Rivera, Laura A. Berkowitz, Karl Riabowol, Douglas A. Harrison, Richard Binari and Norbert Perrimon. Their work appears in journals such as Molecular and Cellular Biology, Proceedings of the National Academy of Sciences, Science, Genes & Development and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.